| Rationalizing the development of live attenuated virus vaccines AS Lauring, JO Jones, R Andino Nature biotechnology 28 (6), 573-579, 2010 | 336 | 2010 |
| Androgens and androgen receptor signaling in prostate tumorigenesis Y Zhou, EC Bolton, JO Jones J Mol Endocrinol 54 (1), R15-R29, 2015 | 200 | 2015 |
| Effects of parabens on adipocyte differentiation P Hu, X Chen, RJ Whitener, ET Boder, JO Jones, A Porollo, J Chen, ... Toxicological sciences 131 (1), 56-70, 2013 | 195 | 2013 |
| TLR9-targeted STAT3 silencing abrogates immunosuppressive activity of myeloid-derived suppressor cells from prostate cancer patients DMS Hossain, SK Pal, D Moreira, P Duttagupta, Q Zhang, H Won, J Jones, ... Clinical Cancer Research 21 (16), 3771-3782, 2015 | 186 | 2015 |
| Evolution of circulating tumor DNA profile from first-line to subsequent therapy in metastatic renal cell carcinoma SK Pal, G Sonpavde, N Agarwal, NJ Vogelzang, S Srinivas, NB Haas, ... European urology 72 (4), 557-564, 2017 | 117 | 2017 |
| Selective activation of estrogen receptor-β transcriptional pathways by an herbal extract A Cvoro, S Paruthiyil, JO Jones, C Tzagarakis-Foster, NJ Clegg, ... Endocrinology 148 (2), 538-547, 2007 | 114 | 2007 |
| Non-competitive androgen receptor inhibition in vitro and in vivo JO Jones, EC Bolton, Y Huang, C Feau, RK Guy, KR Yamamoto, B Hann, ... Proceedings of the National Academy of Sciences 106 (17), 7233-7238, 2009 | 112 | 2009 |
| Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivo JO Jones, AM Arvin Journal of virology 77 (2), 1268-1280, 2003 | 92 | 2003 |
| Inhibition of the NF-κB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo JO Jones, AM Arvin Journal of virology 80 (11), 5113-5124, 2006 | 76 | 2006 |
| Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration‐resistant prostate cancer (CRPC) SK Pal, J Patel, M He, B Foulk, K Kraft, DA Smirnov, P Twardowski, ... Cancer 124 (6), 1216-1224, 2018 | 69 | 2018 |
| Responses to alectinib in ALK-rearranged papillary renal cell carcinoma SK Pal, P Bergerot, N Dizman, C Bergerot, J Adashek, R Madison, ... Eur Urol 74 (1), 124-128, 2018 | 67 | 2018 |
| TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells D Moreira, Q Zhang, DMS Hossain, S Nechaev, H Li, CM Kowolik, ... Oncotarget 6 (19), 17302, 2015 | 63 | 2015 |
| Detection and phenotyping of circulating tumor cells in high-risk localized prostate cancer SK Pal, M He, T Wilson, X Liu, K Zhang, C Carmichael, A Torres, ... Clinical genitourinary cancer 13 (2), 130-136, 2015 | 62 | 2015 |
| The role of peroxisome proliferator-activated receptor gamma in prostate cancer C Elix, SK Pal, JO Jones Asian journal of andrology 20 (3), 238-243, 2018 | 59 | 2018 |
| TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs H Won, D Moreira, C Gao, P Duttagupta, X Zhao, E Manuel, D Diamond, ... Journal of leukocyte biology 102 (2), 423-436, 2017 | 53 | 2017 |
| Ligand-independent and tissue-selective androgen receptor inhibition by pyrvinium M Lim, M Otto-Duessel, M He, L Su, D Nguyen, E Chin, T Alliston, ... ACS chemical biology 9 (3), 692-702, 2014 | 52 | 2014 |
| RNA-seq Reveals Aurora Kinase–Driven mTOR Pathway Activation in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma SK Pal, M He, T Tong, H Wu, X Liu, C Lau, JH Wang, C Warden, X Wu, ... Molecular Cancer Research 13 (1), 130-137, 2015 | 45 | 2015 |
| Reduced T-cell numbers and elevated levels of immunomodulatory cytokines in metastatic prostate cancer patients de novo resistant to abiraterone and/or enzalutamide therapy SK Pal, D Moreira, H Won, SW White, P Duttagupta, M Lucia, J Jones, ... International Journal of Molecular Sciences 20 (8), 1831, 2019 | 43 | 2019 |
| Association of circulating tumor DNA (ctDNA) detection in metastatic renal cell carcinoma (mRCC) with tumor burden MC Maia, PG Bergerot, N Dizman, JA Hsu, J Jones, RB Lanman, ... Kidney Cancer 1 (1), 65-70, 2017 | 43 | 2017 |
| A cellular conformation-based screen for androgen receptor inhibitors JO Jones, MI Diamond ACS chemical biology 3 (7), 412-418, 2008 | 42 | 2008 |
